First Time Loading...
J

Jeisys Medical Inc
KOSDAQ:287410

Watchlist Manager
Jeisys Medical Inc
KOSDAQ:287410
Watchlist
Price: 11 820 KRW -1.42% Market Closed
Updated: Jun 1, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

125.6B
+6%
Assets
Growth Rates:
1 Year
+47%
3 Years
+1 406%
5 Years
+8 963%
7 Years
-
10 Years
-
40.8B
+5%
Liabilities
Growth Rates:
1 Year
+39%
3 Years
+6 314%
5 Years
+6 924%
7 Years
-
10 Years
-
84.9B
+7%
Equity
Growth Rates:
1 Year
+52%
3 Years
+1 001%
5 Years
+10 432%
7 Years
-
10 Years
-

Balance Sheet Decomposition
Jeisys Medical Inc

125.6B
Assets
40.8B
Liabilities
125.6B
Assets
40.8B
Liabilities
Current Assets 88.6B
Cash & Short-Term Investments 52B
Receivables 12.9B
Other Current Assets 23.7B
Non-Current Assets 37B
Long-Term Investments 8.1B
PP&E 22.3B
Intangibles 1.6B
Other Non-Current Assets 5.1B
Current Liabilities 28.7B
Accounts Payable 2.2B
Accrued Liabilities 2.1B
Short-Term Debt 3.3B
Other Current Liabilities 21.2B
Non-Current Liabilities 12B
Long-Term Debt 11.2B
Other Non-Current Liabilities 812m

Balance Sheet
Jeisys Medical Inc

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
1 394
1 168
1 116
25
34 291
39 583
Cash
0
0
0
0
9
0
Cash Equivalents
1 394
1 168
1 116
25
34 282
39 583
Short-Term Investments
0
7 000
7 105
8 210
0
0
Total Receivables
0
84
98
81
7 402
10 916
Accounts Receivables
0
83
82
58
7 057
10 344
Other Receivables
0
0
16
23
344
572
Inventory
0
0
0
0
10 578
20 380
Other Current Assets
0
0
0
0
1 902
3 605
Total Current Assets
1 394
8 252
8 320
8 316
54 173
74 483
PP&E Net
0
0
0
0
10 750
22 140
PP&E Gross
0
0
0
0
10 750
22 140
Accumulated Depreciation
0
0
0
0
7 055
5 916
Intangible Assets
0
0
0
0
969
1 708
Note Receivable
0
0
0
0
0
0
Long-Term Investments
0
0
0
0
258
7 748
Other Long-Term Assets
0
0
0
0
7 908
12 038
Total Assets
1 394
N/A
8 252
+492%
8 320
+1%
8 316
0%
74 059
+791%
118 118
+59%
Liabilities
Accounts Payable
0
0
0
0
2 364
2 310
Accrued Liabilities
2
0
0
0
2 586
3 844
Short-Term Debt
0
0
0
0
3 257
3 287
Current Portion of Long-Term Debt
0
0
0
0
7 365
1 661
Other Current Liabilities
0
0
0
0
8 455
15 482
Total Current Liabilities
2
0
0
0
24 027
26 583
Long-Term Debt
540
563
587
613
1 729
11 315
Deferred Income Tax
26
25
29
20
0
0
Minority Interest
0
0
0
0
568
537
Other Liabilities
0
0
0
0
649
264
Total Liabilities
568
N/A
588
+4%
617
+5%
633
+3%
26 973
+4 160%
38 700
+43%
Equity
Common Stock
74
424
424
424
7 130
7 130
Retained Earnings
6
10
30
9
6 865
33 995
Additional Paid In Capital
758
7 250
7 250
7 250
26 849
26 421
Treasury Stock
0
0
0
0
264
264
Other Equity
0
0
0
1
6 505
12 135
Total Equity
826
N/A
7 663
+828%
7 703
+1%
7 682
0%
47 086
+513%
79 418
+69%
Total Liabilities & Equity
1 394
N/A
8 252
+492%
8 320
+1%
8 316
0%
74 059
+791%
118 118
+59%
Shares Outstanding
Common Shares Outstanding
1
4
4
4
71
71

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 142,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.